IVUS – Measured Optimal Minimal Stent Area in Left Main Crossover Stenting

The current guidelines recommend the use of intravascular ultrasound (IVUS) during left main stenting to optimized PCI outcomes, to make sure devices are well positioned and adequately expanded. Even though there is no standard consensus on the definition of stent underexpansion, minimal stent area (MSA) measured by IVUS, is considered the most reliable predictor of future adverse events after left main PCI. 

Several studies have looked into MSA criteria in two-stent techniques; however, there is still little information on the optimal MSA values in left main PCI when using a single-stent crossover technique. 

The aim of this study was to identify IVUS-derived segmental MSA cutoff after left main crossover stenting aiming at predicting mayor adverse cardiovascular events (MACE) at 5 years.

The primary outcome was 5-year MACE, defined as the combination of all cause death, target vessel related acute MI and clinically driven target lesion revascularization (TLR). 

The study looked at 829 patients undergoing left main PCI towards the left anterior descending artery (LAD), assessed by IVUS after stenting. Patient mean age was 64 and they were mostly men. 37% of cases presented as acute coronary syndrome. Most patients presented single vessel left main disease (35.5%). Left main lesions involved the distal bifurcation in 73% of patients. 

Read also: Impact of Amyloidosis on Outcomes After TAVI.

Final MSA was measured in three segments: proximal LM, distal LM and LAD ostium. Cutoff values that best predicted 5-year MACE were 11.4 mm² for proximal LM (area under the curve [AUC]: 0.62), 8.4 mm² for distal LM (AUC: 0.58) and 8.1 mm² for LAD ostium (AUC: 0.57). Based on these thresholds, stent underexpansion in proximal LM was significantly associated with greater risk of MACE at 5 years (HR: 2.34; p < 0.001). In addition, patients with simultaneous underexpansion in distal LM and LAD ostium presented a significantly higher risk of MACE at 5 years, vs. adequate expansion or limited underexpansion in one single location (HR: 2.57; p < 0.001).

Conclusion 

This study looked at segmental MSA cutoff values assessed by IVUS in patients undergoing left main crossover stenting from the left main to the LAD for unprotected left main disease. Achieving optimal stent expansion in proximal left main and preventing underexpansion both in distal LM and AD ostium is paramount to improve long-term clinical outcomes. The identified optimal MSA thresholds may serve as practical references to stent optimization during left main PCI.

Original Title: Ultrasonido intravascular. Tronco de coronaria izquierda. Optimal minimal stent area after crossover stenting in patients with unprotected left main coronary artery disease.

Reference: Ju Hyeon Kim1, MD, PhD et al Eurointervention 2025;21:e1069-e1080.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...